NEW YORK, October 22, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding 3M Company (NYSE: MMM), Textron Inc. (NYSE: TXT), DR Horton Inc. (NYSE: DHI), Starbucks Corporation (NASDAQ: SBUX) and Cognizant Technology Solutions Corporation (NASDAQ: CTSH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7363-100free.

-- 3M Company Research Reports As per Events & Archived Presentations section of 3M Company's (3M) official website, the Company is scheduled to conduct its Q3 2014 earnings call on Thursday, October 23, 2014. According to Bloomberg Businessweek, analysts expect the Company to report Q3 2014 EPS of $1.98. The full research reports on 3M are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/MMM/report.pdf

-- Textron Inc. Research Reports On October 17, 2014, Textron Inc. (Textron) announced its Q3 FY 2014 (period ended September 27, 2014) earnings results. Total revenues for the quarter were reported at $3.4 billion, up 18.1% YoY. Net income from continuing operations stood at $160 million or $0.57 per diluted share, compared to $98 million or $0.35 per diluted share in Q3 FY 2013. Textron Chairman and CEO Scott C. Donnelly, said, "Revenues at Textron Aviation, Industrial and Bell were up during the quarter, primarily reflecting the success of our new product investment and acquisition strategies. Operationally, we achieved significant margin improvement in the quarter at Textron Aviation, reflecting higher volumes and better performance. Bell also had improved performance, leading to an increase in quarterly margins compared to last year." For FY 2014, Textron increased its EPS from continuing operations guidance to a range of $2.05 to $2.15. The full research reports on Textron are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/TXT/report.pdf

-- DR Horton Inc. Research Reports On October 3, 2014, DR Horton Inc. (DR Horton) announced that the Company will release its Q4 FY 2014 (period ended September 30, 2014) and FY 2014 financial results on Tuesday, November 11, 2014, before the market opens. The Company informed that it will host a conference call on the same day, at 10:00 a.m. ET, and webcast of the call will be available at the Investor Relations section of its website. Additionally, a replay of the call will also be available at the same location through midnight ET on November 18, 2014. The full research reports on DR Horton are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/DHI/report.pdf

-- Starbucks Corporation Research Reports On October 15, 2014, Starbucks Corporation (Starbucks) announced that the Company plans to release its Q4 FY 2014 and FY 2014 financial results on Thursday, October 30, 2014, after the market closes. The release will be followed by a conference call on the same day at 2:00 p.m. PT. Starbucks informed that the conference call will be webcast live and the same can be accessed on the Investor section of its website. A replay of the webcast will also be available on the Company's website until Thursday, November 27, 2014. The full research reports on Starbucks are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/SBUX/report.pdf

-- Cognizant Technology Solutions Corporation Research Reports On October 13, 2014, Cognizant Technology Solutions Corporation (Cognizant), a leading provider of information technology, consulting, and business process outsourcing services, reported that the Company will announce its Q3 2014 results on Wednesday, November 5, 2014, before market opens. Cognizant added that its management will conduct a conference call on the same day, at 8:00 a.m. ET, to discuss operating performance for the quarter. The live webcast of the call will also be available via the Investor section of Cognizant's website. Additionally, the call will also be archived for 60 days on the Company's website. The full research reports on Cognizant are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/CTSH/report.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review